Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction
AUTOR(ES)
Britto, Constança, Silveira, Celeste, Cardoso, Maria Angelica, Marques, Patricia, Luquetti, Alejandro, Macêdo, Vanize, Fernandes, Octavio
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2001-08
RESUMO
Polymerase chain reaction (PCR) was compared with xenodiagnosis performed 20 years after trypanocidal chemotherapy to investigate parasite clearance. Eighty-five seropositive individuals for Chagas disease presenting a positive xenodiagnosis were treated with specific drugs; 37 in the acute phase and 48 in the chronic phase. Fifteen chronic assymptomatic patients received a placebo. Treatment in the acute phase led to PCR negative results in 73% of the cases, while xenodiagnosis was negative in 86%. In the chronic phase, PCR was negative in 65% of the patients and 83% led to xenodiagnosis negative results. Regarding the untreated group (placebo), 73% gave negative results by xenodiagnosis, of which 36% were positive by PCR. Individuals that were considered seronegative (n=10), presented unequivocally negative results in the PCR demonstrating the elimination of parasite DNA. Seventeen individuals had their antibodies titers decreased to such a level that the final results were considered as doubtful and 16 of them presented negative PCR. The molecular method represents a clear advantage over conventional techniques to demonstrate persistent infections in Chagas disease patients that underwent chemotherapy.
Documentos Relacionados
- Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis.
- Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients
- Detection of Theileria sergenti infection in cattle by polymerase chain reaction amplification of parasite-specific DNA.
- Human antithrombin II (AT3) gene length polymorphism revealed by the polymerase chain reaction.
- Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction